BioSpace News Archive

Business

CEVEC signs license agreement for the development and commercialization of exosomes for therapeutic use

CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Evox Therapeutics, Ltd. for the development and commercialization of therapeutic exosomes using CEVEC’s proprietary CAP® technology.

April 21, 2020
·
3 min read
Drug Development

Cara and Vifor’s Korsuva Injection Hits the Mark for Treating Severe Itching in Kidney Patients

“We are very pleased with the positive topline data from our global, pivotal Phase III trial of Korsuva Injection, which reinforce the robust results we reported from our U.S. KALM-1 Phase III trial last year,” said Derek Chalmers, president and chief executive officer of Cara.

April 21, 2020
·
2 min read
·
Mark Terry
Business

Rockefeller Foundation Donates $15 Million to Launch Massive COVID-19 Testing Plan

The Rockefeller Foundation laid out its COVID-19 Testing Action Plan as a fundamental step to reopen the country.

April 21, 2020
·
3 min read
·
Mark Terry
Drug Development

Biopharma Update on the Novel Coronavirus: April 21

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 21, 2020.

April 21, 2020
·
6 min read
·
BioSpace Editorial Staff
Health Organizations Jointly Develop COVID-19 Research Database

The new database includes HIPAA-compliant, de-identified and limited, longitudinal, patient-level data sets from the consortium of institutions and organizations that helped develop it.

April 21, 2020
·
2 min read
·
Alex Keown
Drug Development

SCYNEXIS Posts Positive Phase III Data with Oral Treatment, Ibrexafungerp, for Vaginal Yeast

Results of ibrexafungerp were announced today from the VANISH-306 trial, along with previously announced results from VANISH 303. Here’s more about it.

April 21, 2020
·
2 min read
·
Alex Keown
Drug Development

Could Llamas Hold the Key to a COVID-19 Vaccine?

Could antibodies found in the blood of llamas, the doe-eyed South American pack animal, hold a key to developing a vaccine for COVID-19? A team of researchers from Belgium believes so.

April 21, 2020
·
3 min read
·
Alex Keown
Drug Development

Big Pharma Calls for More Funding and Coordination to Battle COVID-19 Pandemic

At least some of the concern is that without greater funding and coordination, the companies won’t be able to buy sufficient raw materials, continue production of existing drugs and quickly scale up their capacity to meet the demand of new drugs and older therapies around the world.

April 21, 2020
·
4 min read
·
Mark Terry
Business

Esperion and Otsuka Team Up for Cardiovascular Drug Development and Commercialization in Japan

The collaboration for development and commercialization combines Esperion’s knowledge in lipid management and Otsuka’s extensive cardiovascular drug advancement and marketing in Japan.

April 21, 2020
·
2 min read
·
Michelle Brugioni
Drug Development

Vaxart Plans to Push COVID-19 Vaccine Candidate into the Clinic

Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.

April 21, 2020
·
2 min read
·
Alex Keown